Company or ticker...

Company or ticker...

BioTech

argenx

Argenx is develops new antibody-based medicines to treat serious autoimmune diseases and cancer.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

ARGX

52.5B

14.4

36.5

0.18%

Key Facts

M. Cap

PS

PE

YTD

52.5B

14.4

36.5

0.18%

10MA

20MA

50MA

200MA

$ARGX